These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 36322849)

  • 1. Psilocybin in Treatment-Resistant Depression.
    Madras BK
    N Engl J Med; 2022 Nov; 387(18):1708-1709. PubMed ID: 36322849
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.
    Fang Q; Chan VKY; Chan SSM; Jiao Y; Wang J; Li X
    Psychiatry Res; 2024 Jul; 337():115960. PubMed ID: 38781672
    [No Abstract]   [Full Text] [Related]  

  • 3. Psilocybin for the Treatment of Depression: A Promising New Pharmacotherapy Approach.
    Agin-Liebes G; Davis AK
    Curr Top Behav Neurosci; 2022; 56():125-140. PubMed ID: 34811715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psilocybin for Treatment-Resistant Depression.
    Lengvenyte A; Olié E; Courtet P
    N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812445
    [No Abstract]   [Full Text] [Related]  

  • 5. Psilocybin for Treatment-Resistant Depression.
    Roméo B; Dervaux A; Benyamina A
    N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812444
    [No Abstract]   [Full Text] [Related]  

  • 6. Psilocybin for Treatment-Resistant Depression.
    Østergaard SD; Hieronymus F
    N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812443
    [No Abstract]   [Full Text] [Related]  

  • 7. Psilocybin for Treatment-Resistant Depression. Reply.
    Goodwin GM; Hellerstein DJ; Young AH
    N Engl J Med; 2023 Feb; 388(8):e22. PubMed ID: 36812446
    [No Abstract]   [Full Text] [Related]  

  • 8. Why didn't the TGA consult with Australian researchers and clinicians with experience in psilocybin-assisted psychotherapy for treatment-resistant major depressive disorder?
    Rossell SL; Meikle SE; Williams ML; Castle DJ
    Aust N Z J Psychiatry; 2023 Jul; 57(7):935-936. PubMed ID: 37139585
    [No Abstract]   [Full Text] [Related]  

  • 9. Role of Psychedelics in Treatment-Resistant Depression.
    Kamal S; Jha MK; Radhakrishnan R
    Psychiatr Clin North Am; 2023 Jun; 46(2):291-305. PubMed ID: 37149346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psilocybin with psychological support improves emotional face recognition in treatment-resistant depression.
    Stroud JB; Freeman TP; Leech R; Hindocha C; Lawn W; Nutt DJ; Curran HV; Carhart-Harris RL
    Psychopharmacology (Berl); 2018 Feb; 235(2):459-466. PubMed ID: 29085980
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psilocybin reduces symptoms in treatment resistant depression, trial results show.
    Iacobucci G
    BMJ; 2022 Nov; 379():o2623. PubMed ID: 36411539
    [No Abstract]   [Full Text] [Related]  

  • 12. Return of the psychedelics: Psilocybin for treatment resistant depression.
    Patra S
    Asian J Psychiatr; 2016 Dec; 24():51-52. PubMed ID: 27931907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.
    Carhart-Harris RL; Bolstridge M; Day CMJ; Rucker J; Watts R; Erritzoe DE; Kaelen M; Giribaldi B; Bloomfield M; Pilling S; Rickard JA; Forbes B; Feilding A; Taylor D; Curran HV; Nutt DJ
    Psychopharmacology (Berl); 2018 Feb; 235(2):399-408. PubMed ID: 29119217
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.
    Wulff AB; Nichols CD; Thompson SM
    Neuropharmacology; 2023 Jun; 231():109504. PubMed ID: 36921889
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Natural speech algorithm applied to baseline interview data can predict which patients will respond to psilocybin for treatment-resistant depression.
    Carrillo F; Sigman M; Fernández Slezak D; Ashton P; Fitzgerald L; Stroud J; Nutt DJ; Carhart-Harris RL
    J Affect Disord; 2018 Apr; 230():84-86. PubMed ID: 29407543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Esketamine and Psilocybin-The Comparison of Two Mind-Altering Agents in Depression Treatment: Systematic Review.
    Psiuk D; Nowak EM; Dycha N; Łopuszańska U; Kurzepa J; Samardakiewicz M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are Magic Mushrooms Really Magic?: Psilocybin in the Treatment of Depression.
    Balon R
    J Clin Psychopharmacol; 2022 Nov-Dec 01; 42(6):515-516. PubMed ID: 36251379
    [No Abstract]   [Full Text] [Related]  

  • 18. Therapeutic mechanisms of psilocybin: Changes in amygdala and prefrontal functional connectivity during emotional processing after psilocybin for treatment-resistant depression.
    Mertens LJ; Wall MB; Roseman L; Demetriou L; Nutt DJ; Carhart-Harris RL
    J Psychopharmacol; 2020 Feb; 34(2):167-180. PubMed ID: 31941394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study.
    Breeksema JJ; Niemeijer A; Krediet E; Karsten T; Kamphuis J; Vermetten E; van den Brink W; Schoevers R
    Sci Rep; 2024 Feb; 14(1):2929. PubMed ID: 38316896
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How ecstasy and psilocybin are shaking up psychiatry.
    Tullis P
    Nature; 2021 Jan; 589(7843):506-509. PubMed ID: 33505033
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.